Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation
- 16 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 36 (1), 257-262
- https://doi.org/10.1038/s41375-021-01312-3
Abstract
Clonal hematopoiesis (CH) is associated with older age and an increased risk of myeloid malignancies and cardiovascular complications. We analyzed donor DNA samples in patients with AML/MDS who underwent first allogeneic stem cell transplant (SCT) to investigate the association between donor CH and transplant outcomes. We performed targeted deep sequencing of 300 genes on donor blood samples and identified CH with the minimum variant allele frequency of 2%. Among 363 donors, 65 (18%) had CH. The most frequently mutated genes were DNMT3A (31 of 65; 48%), TET2 (16 of 65; 25%), PPM1D (5 of 65, 8%), and ASXL1 (7 of 65; 11%). Transplant outcomes: time to neutrophil and platelet recovery, relapse incidence, transplant-related mortality and progression-free survival, were comparable by donor CH. However, risk of grade II–IV and III–IV acute graft versus host disease (aGvHD) at 6 months after transplant was higher with donor CH vs. without donor CH (hazard ratio (HR) = 2.4, 95% Confidence Interval (CI) = 1.6–3.6, p < 0.001 and HR = 3.8, 95% CI = 1.6–8.9, p = 0.003). In this homogenous population of AML/MDS patients, donor CH was associated with increased risk of grade II–IV and III–IV aGvHD. Further studies to investigate the mechanisms of increased aGvHD and therapeutic interventions to improve aGvHD in the context of donor CH are warranted.This publication has 18 references indexed in Scilit:
- Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantationEuropean Heart Journal, 2020
- Clonal hematopoiesis in patients with rheumatoid arthritisBlood Cancer Journal, 2018
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseThe New England Journal of Medicine, 2017
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesBlood, 2015
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA SequenceThe New England Journal of Medicine, 2014
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesThe New England Journal of Medicine, 2014
- Age-related mutations associated with clonal hematopoietic expansion and malignanciesNature Medicine, 2014
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaBlood, 2011
- Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor ageBlood, 2001
- The Aging Immune System: Primer and ProspectusScience, 1996